FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4409111000001109: Dinoprostone 400micrograms/ml vaginal gel 2.5 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21580501000001111 Dinoprostone 400micrograms/ml vaginal gel 2.5 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58632001000001117 Dinoprostone 1mg/2.5ml vaginal gel 2.5 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Is pack of Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel false Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Has active ingredient Alprostadil false Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Has active ingredient Posterior pituitary hormone false Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Has active ingredient Dinoprostone false Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Has VMP Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel true Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Has specific active ingredient Dinoprostone true Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Has dispensed dose form Conventional release vaginal gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Prostin E2 1mg vaginal gel (Pfizer Ltd) 2.5 ml Is a True Dinoprostone 400micrograms/ml vaginal gel 2.5 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start